Paragon 28 (NYSE:FNA) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research cut shares of Paragon 28 (NYSE:FNA) from a hold rating to a sell rating in a research report released on Tuesday, Zacks.com reports.

According to Zacks, “Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo. “

Several other analysts have also recently weighed in on the company. assumed coverage on Paragon 28 in a report on Tuesday, November 9th. They set a buy rating and a $28.00 price target for the company. JMP Securities reissued a buy rating and set a $29.00 price target on shares of Paragon 28 in a report on Tuesday, November 23rd. Needham & Company LLC reissued a buy rating and set a $31.00 price target on shares of Paragon 28 in a report on Monday, January 10th. Finally, Piper Sandler began coverage on Paragon 28 in a research note on Tuesday, November 9th. They set an overweight rating and a $30.00 price objective on the stock. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of Buy and an average price target of $29.50.

FNA opened at $16.35 on Tuesday. Paragon 28 has a 12-month low of $12.87 and a 12-month high of $25.41. The company has a 50 day simple moving average of $18.56. The company has a quick ratio of 1.19, a current ratio of 2.48 and a debt-to-equity ratio of 0.96.

Paragon 28 (NYSE:FNA) last released its quarterly earnings data on Monday, November 22nd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.08) by ($0.04). The firm had revenue of $35.85 million during the quarter, compared to the consensus estimate of $34.95 million. As a group, equities research analysts anticipate that Paragon 28 will post -0.25 earnings per share for the current fiscal year.

Paragon 28 Company Profile

Paragon 28 Inc is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc is based in ENGLEWOOD, Colo.

Recommended Story: How to Profit and Limit Losses With Stop Orders

Get a free copy of the Zacks research report on Paragon 28 (FNA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.